WAVE Life Sciences (WVE) Priced

Preclinical biotech developing optimized RNA therapies for rare diseases.

Health Care - Biotechnology

IPO Performance
Latest Trade $28.05 0.00 (0.0%)
First Day Return 0.0%
Return from IPO 75.3%
 
WAVE Life Sciences IPO News more
  • .
IPO Data
IPO File Date 10/09/2015
Offer Price $16.00
Price Range $15.00 - $17.00
Offer Shares (mm) 6.4
Deal Size ($mm) 102
 
IPO Data
IPO Date 11/10/2015
Offer Price $16.00
Price Range $15.00 - $17.00
Offer Shares (mm) 6.4
Deal Size ($mm) $102
 
Underwriters
more
Business Overview
Preclinical biotech developing optimized RNA therapies for rare diseases.
Preclinical biotech developing optimized RNA therapies for rare diseases.
more
Company Data
Headquarters Singapore, , Singapore
Founded 2012
Employees 28
Website www.wavelifesciences.com
 

Performance vs. IPO Index (IPOUSA)